Compare DLHC & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DLHC | ARAY |
|---|---|---|
| Founded | 1969 | 1990 |
| Country | United States | United States |
| Employees | 2300 | N/A |
| Industry | Business Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.8M | 68.6M |
| IPO Year | 2012 | 2006 |
| Metric | DLHC | ARAY |
|---|---|---|
| Price | $5.68 | $0.34 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $3.50 |
| AVG Volume (30 Days) | 5.4K | ★ 1.4M |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 87.50 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $41,923,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.05 | $4.58 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 2.57 | N/A |
| 52 Week Low | $2.72 | $0.33 |
| 52 Week High | $8.09 | $2.10 |
| Indicator | DLHC | ARAY |
|---|---|---|
| Relative Strength Index (RSI) | 43.95 | 30.10 |
| Support Level | $5.55 | $0.33 |
| Resistance Level | $6.02 | $0.63 |
| Average True Range (ATR) | 0.29 | 0.05 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 10.65 | 6.54 |
DLH Holdings Corp delivers health and readiness solutions for federal government customers through digital transformation and cyber security, science research and development, and systems engineering and integration. It provides technology-enabled business process, program management, and digital transformation solutions to U.S. government agencies, focusing on large-scale, technology-powered health and defense initiatives for agencies including HHS, VA, DoD, and their sub-agencies. Its revenues come from technology-enabled business process outsourcing, program management solutions, and public health research and analytics under time-and-materials, cost-reimbursable, and firm-fixed-price contracts.
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.